A5016281702- Reproductive Biology and Fertility
- Ovarian function and disorders
- Ovarian cancer diagnosis and treatment
- Maternal and fetal healthcare
- Assisted Reproductive Technology and Twin Pregnancy
- Genomic variations and chromosomal abnormalities
- Viral Infections and Vectors
- Virology and Viral Diseases
- Anorectal Disease Treatments and Outcomes
- Urinary Bladder and Prostate Research
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Maternal and Perinatal Health Interventions
- Pelvic floor disorders treatments
- BRCA gene mutations in cancer
- Pregnancy and preeclampsia studies
- Cardiovascular Issues in Pregnancy
- Mosquito-borne diseases and control
- Global Maternal and Child Health
- Prenatal Screening and Diagnostics
- Ectopic Pregnancy Diagnosis and Management
Azienda Ospedaliera Universitaria Integrata Verona
2020-2023
University of Verona
2014-2023
Cochrane
2017
Figure S1. Ultrasonographic image of transverse trans-ventricular section with the measurement biparietal diameter (BPD) and head circumference (HC), both them below 5th centile, showing microcephaly. Hyperechogenic spots suggestive for small parenchymal calcifications (red arrows). S2. fetal profile placenta: scattered in placenta Please note: The publisher is not responsible content or functionality any supporting information supplied by authors. Any queries (other than missing content)...
Fertility preservation (FP) and monitoring has considerable relevance in the multidisciplinary approach to cancer patients. In these consensus-based practical recommendations, scientific societies Fondazione Italiana Linfomi (FIL) Società della Riproduzione Umana (SIRU) reviewed main aspects identified optimal paths which aim preserve monitor fertility patients diagnosed with lymphoma at different phases of disease during long-term survivorship.
Objective Female patients treated with alkylating agents in childhood are at risk for ovarian impairment. We aimed describing the pattern of residual function a cohort survivors hematological malignancies and/or hematopoietic stem cell transplantation (HSCT) and assessing relationship between cyclophosphamide equivalent dose (CED) anti-Müllerian hormone (AMH). Design methods Gonadal health was clinically biochemically assessed 124 post-menarchal who underwent treatment pediatric HSCT 1992...
Childhood and adolescent cancer survivors (CACSs) are at risk of adverse reproductive outcomes. Assessment follicle-stimulating hormone (FSH) levels is the most common test used to diagnose premature ovarian insufficiency (POI) whereas anti-m|llerian (AMH) antral follicle count (AFC) have been proposed as reserve markers. We assessed correlation between these markers treatment gonadotoxicity (GR) in CACSs.A total 55 female CACSs were enrolled. GR was graded low, medium, or high according...
Abstract Background Xq duplication is a rare condition with very variable phenotype, which could mimic other genetic syndromes involving the long arm of chromosome X. Sometimes short stature and diminished ovarian reserve (DOR) may be present. Treatments rGH (Recombinant growth Hormon) or fertility preservation strategies have not been previously described. Case presentation We present case female novel de novo partial (karyotype: 46,Xder(X)(qter→q21.31::pter→qter) confirmed by array-CGH...
Has the practice of individualizing recombinant-FSH starting dose been superseded after largest randomized controlled trial (RCT) in assisted reproduction technology (ART), OPTIMIST trial?The has influenced our ART daily to a limited degree, but adherence is still generally poor.Although 'one size fits all' approach discouraged for decades by most authors, study group demonstrated large prospective RCT that, general, dosage individualization does not improve prospects live birth, although it...
This practical treatment protocol was developed by an experienced multidisciplinary team following a critical and updated systematic review of the literature.
Background: In this consensus-based position paper, the scientific societies Fondazione Italiana Linfomi (FIL) and Società della Riproduzione Umana (SIRU) reviewed main aspects identified optimal paths aimed to preserve monitor fertility in patients diagnosed with lymphoma. Methods: The multi-disciplinary working group for paper was composed by 5 onco-hematologists, 4 gynecologist or andrologists, 1 embryologist biologist, supervision of an international expert leader. A series rank-ordering...